WFRF:(Hellström Per)
Sökning: WFRF:(Hellström Per) > The NIMO Scandinavi...
- 8 av 555
- Föregående post
- Nästa post
- Till träfflistan
The NIMO Scandinavian Study : A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency
-
- Frigstad, Svein Oskar (författare)
- Vestre Viken Hosp Trust, Baerum Hosp, Dept Med, Drammen, Norway.;Univ Oslo, Inst Clin Med, Oslo, Norway.
-
- Haaber, Anne (författare)
- Gentofte Univ Hosp, Dept Gastroenterol, Hellerup, Denmark.
-
- Bajor, Antal (författare)
- Sodra Alvsborg Hosp, Dept Internal Med, Boras, Sweden.
- visa fler...
- visa färre...
- Vestre Viken Hosp Trust, Baerum Hosp, Dept Med, Drammen, Norway;Univ Oslo, Inst Clin Med, Oslo, Norway. Gentofte Univ Hosp, Dept Gastroenterol, Hellerup, Denmark. (creator_code:org_t)
- Hindawi Limited, 2017
- 2017
- Engelska.
- Ingår i: Gastroenterology Research and Practice. - : Hindawi Limited. - 1687-6121 .- 1687-630X. ; 2017
- Tidskriftsartikel (refereegranskat)
Abstract
Ämnesord
Stäng
- Background. Intravenous iron allows for efficient and well-tolerated treatment in iron deficiency and is routinely used in diseases of the gastrointestinal tract. Objective. The aims of this study were to determine the probability of relapse of iron deficiency over time and to investigate treatment routine, effectiveness, and safety of iron isomaltoside. Methods. A total of 282 patients treated with iron isomaltoside were observed for two treatments or a minimum of one year. Results. Out of 282 patients, 82 had Crohn's disease and 67 had ulcerative colitis. Another 133 patients had chronic blood loss, malabsorption, or malignancy. Patients who received an iron isomaltoside dose above 1000 mg had a 65% lower probability of needing retreatment compared with those given 1000 mg. A clinically significant treatment response was shown, but in 71/191 (37%) of patients, anaemia was not corrected. The mean dose given was 1100 mg, lower than the calculated total iron need of 1481 mg. Adverse drug reactions were reported in 4% of patients. Conclusion. Iron isomaltoside is effective with a good safety profile, and high doses reduce the need for retreatment over time. Several patients were anaemic after treatment, indicating that doses were inadequate for full iron correction.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Gastroenterologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
- Gastroenterology Research and Practice (Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- 8 av 555
- Föregående post
- Nästa post
- Till träfflistan
Hitta mer i SwePub
- Av författaren/redakt...
- Frigstad, Svein ...
- Haaber, Anne
- Bajor, Antal
- Fallingborg, Jan
- Hammarlund, Per
- Bonderup, Ole K.
- visa fler...
- Blom, Hakan
- Rannem, Terje
- Hellström, Per M ...
- visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
- MEDICIN OCH HÄLS ...
- och Klinisk medicin
- och Gastroenterologi
- Artiklar i publikationen
- Gastroenterology ...
- Av lärosätet
- Uppsala universitet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
